A Follow-on Study for Second-Eye Treatment for Participants Previously Treated With Gene Therapy for X-Linked Retinitis Pigmentosa (XLRP)
Clinical trial NCT06646289 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06646289
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-10
- Primary completion
- 2030-10-24
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.